Druckenmiller's family office — high-conviction macro expressed through equities.
| # | Holding | Our call | % of book | Value | Shares | QoQ |
|---|---|---|---|---|---|---|
| 1 | NTRA | Hold | 20.9% | $613K | 3.06M | Added+22% |
| 2 | INSM | Hold | 6.4% | $189K | 1.15M | Trimmed-22% |
| 3 | TSM | Sell | 5.7% | $167K | 495K | Trimmed-9% |
| 4 | EWZCall | — | — | $162K | 4.23M | — |
| 5 | RSPCall | — | — | $158K | 821K | NEW |
| 6 | YPF | Avoid | 5.1% | $150K | 3.24M | Added+433% |
| 7 | EWZ | — | 4.5% | $132K | 3.44M | Trimmed-3% |
| 8 | TBBB | — | 3.7% | $110K | 3.11M | Added+16% |
| 9 | AA | Buy | 3.4% | $99.1K | 1.49M | Added+9% |
| 10 | NAMS | Hold | 3.3% | $98.3K | 3.07M | — |
| 11 | SE | Buy | 3.1% | $91.1K | 1.10M | Added+17% |
| 12 | STM | Hold | 3.1% | $90.3K | 2.61M | Added+238% |
| 13 | WWD | Hold | 2.6% | $75.6K | 211K | Trimmed-64% |
| 14 | TEVA | Hold | 2.4% | $71.6K | 2.38M | Trimmed-60% |
| 15 | ROKU | Hold | 2.4% | $71.0K | 750K | Added+29% |
| 16 | AVGO | Hold | 2.1% | $60.6K | 196K | NEW |
| 17 | SPYCall | — | — | $58.5K | 90.0K | — |
| 18 | CPNG | Hold | 1.7% | $50.4K | 2.67M | Trimmed-61% |
| 19 | Option Care Health Inc | — | 1.7% | $50.3K | 1.87M | Added+7% |
| 20 | AMZNCall | Buy | — | $41.7K | 200K | Added+100% |
| 21 | CRH | Buy | 1.4% | $39.7K | 378K | Trimmed-21% |
| 22 | FIGR | Buy | 1.3% | $39.1K | 1.15M | Trimmed-25% |
| 23 | ARGT | — | 1.2% | $36.2K | 387K | NEW |
| 24 | CAI | Buy | 1.2% | $33.9K | 1.89M | NEW |
| 25 | QSR | Hold | 1.1% | $33.6K | 454K | Trimmed-62% |
| 26 | RVMD | Avoid | 1.0% | $30.7K | 316K | NEW |
| 27 | LSCC | Sell | 1.0% | $30.0K | 323K | Trimmed-65% |
| 28 | SNDK | Avoid | 0.8% | $24.2K | 38.2K | NEW |
| 29 | UAL | Hold | 0.8% | $24.2K | 262K | Trimmed-25% |
| 30 | HUM | Hold | 0.8% | $23.8K | 138K | NEW |
| 31 | WAB | Hold | 0.8% | $23.7K | 94.9K | Trimmed-68% |
| 32 | TWLO | Hold | 0.8% | $22.9K | 182K | NEW |
| 33 | JBL | Hold | 0.7% | $21.8K | 82.2K | NEW |
| 34 | SCCO | Hold | 0.7% | $21.0K | 122K | — |
| 35 | GSG | — | 0.7% | $20.7K | 643K | NEW |
| 36 | LIN | Hold | 0.7% | $20.4K | 41.2K | NEW |
| 37 | STX | Sell | 0.7% | $19.9K | 50.7K | NEW |
| 38 | IWMCall | — | — | $19.6K | 79.0K | Trimmed-65% |
| 39 | CLF | Sell | 0.7% | $19.5K | 2.31M | Added+33% |
| 40 | NUVB | Hold | 0.7% | $19.5K | 4.54M | NEW |
| 41 | BE | Sell | 0.6% | $18.5K | 136K | Trimmed-82% |
| 42 | INTC | Sell | 0.6% | $18.2K | 411K | NEW |
| 43 | BLTE | Hold | 0.6% | $16.9K | 106K | NEW |
| 44 | PTGX | Hold | 0.6% | $16.8K | 160K | — |
| 45 | U | Hold | 0.6% | $16.2K | 739K | Added+80% |
| 46 | ARM | Sell | 0.5% | $16.1K | 107K | NEW |
| 47 | Olema Pharmaceuticals Inc | — | 0.5% | $14.7K | 987K | NEW |
| 48 | Q | Sell | 0.5% | $14.5K | 126K | NEW |
| 49 | ADMA | Buy | 0.5% | $13.9K | 1.55M | Added+513% |
| 50 | XENE | Hold | 0.5% | $13.9K | 239K | NEW |
| 51 | Jbs N.V. | — | 0.4% | $11.8K | 656K | NEW |
| 52 | DAKT | Buy | 0.4% | $11.0K | 563K | Trimmed-34% |
| 53 | NET | Hold | 0.4% | $10.8K | 52.5K | NEW |
| 54 | LYB | Hold | 0.4% | $10.6K | 131K | NEW |
| 55 | VIST | — | 0.3% | $10.2K | 135K | NEW |
| 56 | TWST | Hold | 0.3% | $9.79K | 206K | NEW |
| 57 | COHR | Hold | 0.3% | $9.62K | 40.4K | NEW |
| 58 | AMZN | Buy | 0.3% | $9.54K | 45.8K | Trimmed-94% |
| 59 | CLS | Hold | 0.3% | $9.37K | 33.3K | NEW |
| 60 | STUB | Hold | 0.3% | $8.53K | 1.37M | Trimmed-41% |
| 61 | DBVT | Avoid | 0.3% | $8.01K | 383K | NEW |
| 62 | MU | Sell | 0.3% | $7.91K | 23.4K | NEW |
| 63 | SATS | Hold | 0.2% | $7.11K | 60.8K | — |
| 64 | ALM | Sell | 0.2% | $6.80K | 470K | — |
| 65 | PCT | Avoid | 0.2% | $5.00K | 963K | Trimmed-67% |
| 66 | LITE | Sell | 0.2% | $4.89K | 6.96K | NEW |
| 67 | MELI | Hold | 0.2% | $4.78K | 2.77K | Trimmed-94% |
| 68 | SOLS | Hold | 0.2% | $4.76K | 62.5K | NEW |
| 69 | WLK | Hold | 0.1% | $2.48K | 21.2K | NEW |
| 70 | WVE | Hold | 0.0% | $1.25K | 173K | — |
Source: SEC Form 13F-HR. Positions are as-of quarter end (filed up to 45 days later) and cover US-listed equities only — shorts, non-US listings and most derivatives don’t appear. Values as reported by the filer. “Our call” is TENK/calls’s independent SEC-grounded verdict, not the fund’s view.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.